PT76870A - Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them - Google Patents
Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing themInfo
- Publication number
- PT76870A PT76870A PT76870A PT7687083A PT76870A PT 76870 A PT76870 A PT 76870A PT 76870 A PT76870 A PT 76870A PT 7687083 A PT7687083 A PT 7687083A PT 76870 A PT76870 A PT 76870A
- Authority
- PT
- Portugal
- Prior art keywords
- dihydropiridine
- derivatives
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH369382 | 1982-06-15 | ||
CH369282 | 1982-06-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
PT76870A true PT76870A (en) | 1983-07-01 |
PT76870B PT76870B (en) | 1986-02-27 |
Family
ID=25693638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT76870A PT76870B (en) | 1982-06-15 | 1983-06-14 | Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them |
Country Status (19)
Country | Link |
---|---|
AU (1) | AU1575383A (pt) |
BE (1) | BE897000A (pt) |
CA (1) | CA1208639A (pt) |
CH (1) | CH660593A5 (pt) |
DE (1) | DE3320616A1 (pt) |
DK (1) | DK271183A (pt) |
ES (2) | ES8504179A1 (pt) |
FI (1) | FI832072L (pt) |
FR (1) | FR2528431B1 (pt) |
GB (1) | GB2122192B (pt) |
HU (1) | HU191853B (pt) |
IT (1) | IT1178353B (pt) |
NL (1) | NL8302067A (pt) |
NZ (1) | NZ204536A (pt) |
PH (1) | PH23436A (pt) |
PT (1) | PT76870B (pt) |
SE (1) | SE8303385L (pt) |
WO (1) | WO1984000033A1 (pt) |
ZA (1) | ZA834409B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3431152A1 (de) * | 1984-08-24 | 1986-03-06 | Cassella Ag, 6000 Frankfurt | Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel |
GB8428552D0 (en) * | 1984-11-12 | 1984-12-19 | Sandoz Ltd | Organic compounds |
US5260321A (en) * | 1984-11-12 | 1993-11-09 | Sandoz Ltd. | Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins |
DE3447169A1 (de) * | 1984-12-22 | 1986-07-03 | Bayer Ag, 5090 Leverkusen | Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln |
US4920225A (en) * | 1986-12-22 | 1990-04-24 | Laboratoires Syntex S.A. | Resolution of 1,4-dihydropyridine derivatives |
EP0287828A1 (de) * | 1987-03-27 | 1988-10-26 | Byk Gulden Lomberg Chemische Fabrik GmbH | Neue Zwischenprodukte und Verfahren |
DE4041814A1 (de) * | 1990-12-24 | 1992-07-02 | Byk Gulden Lomberg Chem Fab | Verfahren zur herstellung von dihydrophyridincarbonsaeuren |
US5135936A (en) * | 1991-03-05 | 1992-08-04 | Marion Merrell Dow Inc. | Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists |
CN100425599C (zh) * | 2005-12-31 | 2008-10-15 | 清华大学 | 一种有机电致发光材料及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK149855C (da) * | 1977-06-20 | 1987-04-21 | Sandoz Ag | Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater |
CH639659A5 (de) * | 1978-12-18 | 1983-11-30 | Sandoz Ag | Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung. |
DE2949464A1 (de) * | 1978-12-18 | 1980-06-26 | Sandoz Ag | Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung |
FI813460L (fi) * | 1980-11-10 | 1982-05-11 | Sandoz Ag | Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner |
-
1983
- 1983-06-07 FR FR8309551A patent/FR2528431B1/fr not_active Expired
- 1983-06-08 FI FI832072A patent/FI832072L/fi not_active Application Discontinuation
- 1983-06-08 DE DE3320616A patent/DE3320616A1/de not_active Withdrawn
- 1983-06-09 BE BE1/10806A patent/BE897000A/fr not_active IP Right Cessation
- 1983-06-10 WO PCT/CH1983/000073 patent/WO1984000033A1/de unknown
- 1983-06-10 NL NL8302067A patent/NL8302067A/nl not_active Application Discontinuation
- 1983-06-10 CH CH688/84A patent/CH660593A5/de not_active IP Right Cessation
- 1983-06-13 NZ NZ204536A patent/NZ204536A/en unknown
- 1983-06-13 DK DK271183A patent/DK271183A/da not_active Application Discontinuation
- 1983-06-13 IT IT48488/83A patent/IT1178353B/it active
- 1983-06-13 CA CA000430300A patent/CA1208639A/en not_active Expired
- 1983-06-13 GB GB08316054A patent/GB2122192B/en not_active Expired
- 1983-06-14 PT PT76870A patent/PT76870B/pt unknown
- 1983-06-14 PH PH29057A patent/PH23436A/en unknown
- 1983-06-14 ES ES523243A patent/ES8504179A1/es not_active Expired
- 1983-06-14 HU HU832113A patent/HU191853B/hu unknown
- 1983-06-14 AU AU15753/83A patent/AU1575383A/en not_active Abandoned
- 1983-06-14 SE SE8303385A patent/SE8303385L/xx not_active Application Discontinuation
- 1983-06-15 ZA ZA834409A patent/ZA834409B/xx unknown
-
1984
- 1984-11-30 ES ES538157A patent/ES8604578A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NZ204536A (en) | 1986-09-10 |
GB2122192A (en) | 1984-01-11 |
CH660593A5 (de) | 1987-05-15 |
DK271183A (da) | 1983-12-16 |
FR2528431A1 (fr) | 1983-12-16 |
BE897000A (fr) | 1983-12-09 |
ES8604578A1 (es) | 1986-02-01 |
GB2122192B (en) | 1985-12-18 |
GB8316054D0 (en) | 1983-07-20 |
PH23436A (en) | 1989-08-07 |
DE3320616A1 (de) | 1983-12-15 |
FI832072L (fi) | 1983-12-16 |
SE8303385D0 (sv) | 1983-06-14 |
ZA834409B (en) | 1985-02-27 |
WO1984000033A1 (en) | 1984-01-05 |
ES523243A0 (es) | 1985-04-01 |
FR2528431B1 (fr) | 1986-01-10 |
ES538157A0 (es) | 1986-02-01 |
SE8303385L (sv) | 1983-12-16 |
CA1208639A (en) | 1986-07-29 |
AU1575383A (en) | 1983-12-22 |
HU191853B (en) | 1987-04-28 |
IT8348488A0 (it) | 1983-06-13 |
ES8504179A1 (es) | 1985-04-01 |
PT76870B (en) | 1986-02-27 |
DK271183D0 (da) | 1983-06-13 |
IT1178353B (it) | 1987-09-09 |
FI832072A0 (fi) | 1983-06-08 |
NL8302067A (nl) | 1984-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT84964A (en) | Process for the preparation of 1,5-diaryl-3-substituted-pyrazoles and of pharmaceutical compositions containing them | |
DE3366393D1 (en) | Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same | |
IL62082A0 (en) | -lactam derivatives,process for the preparation thereof and pharmaceutical compositions containing them | |
PT81007A (en) | Process for the preparation of analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives and of pharmaceutical compositions containing the same | |
PT76809A (en) | Process for preparing 1-sulfo-2-oxoazetidine derivatives and of pharmaceutical compositions containing the same | |
PT76523B (en) | Process for preparing phenoxyalkylcarboxylic acid derivatives and of pharmaceutical compositions containing the same | |
DE3275296D1 (en) | Azabicyclo-(3,3,1)-nonylbenzamide derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
EG17710A (en) | Process for the preparation isosilybin-free silbinin and pharmaceutical compositions containing them | |
PT81502A (en) | Process for the preparation of cholecalciferol derivatives and of pharmaceutical compositions containing the same | |
PT76657B (en) | Process for preparing 4-aryl-4-piperidinecarbinols and of pharmaceutical compositions containing the same | |
PT77217A (en) | Process for preparing 3-phenoxy-1-azetidine-carboxamides and of pharmaceutical compositions containing the same | |
IL69735A (en) | 1-phenyl-1-aminoalkyl-cyclobutane derivatives,process for their preparation and pharmaceutical compositions containing them | |
IL68680A (en) | 2,3,4-trinor-1,5-inter-m-phenylene-prostacyclin-i2-analogues,process for their preparation and pharmaceutical compositions containing them | |
PT76870B (en) | Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them | |
PT75042B (en) | Process for the preparation of apovincaminates and pharmaceutical compositions containing them | |
PT80824A (en) | Process for the preparation of phenylquinoline derivatives and of pharmaceutical compositions containing the same | |
PT79389B (en) | Process for the preparation of 1,2-dithyolane derivates and pharmaceutical compositions containing said derivates | |
PT79199A (en) | Process for preparing 3-indolecarboxamide derivatives and of pharmaceutical compositions containing the same | |
PT76110B (en) | Process for the preparation of 3,3-dialkyl indoline and 3,3-alkylene-indoline derivatives and of pharmaceutical compositions containing them | |
PT74400B (en) | Process for the preparation of 17,18-dehydro-apovincaminol-3', 4',5'-trimethoxy-benzoate and of pharmaceutical compositions containing them | |
DE3368933D1 (en) | Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same | |
PT77282A (en) | Process for preparing substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols and of pharmaceutical compositions containing the same | |
PT83231A (en) | Process for the preparation of gem-dihalo-1,8-diamino-4-aza-octanes and of pharmaceutical compositions containing the same | |
PT77730A (en) | Process for preparing acridanone derivatives and of pharmaceutical compositions containing the same | |
DE3267034D1 (en) | Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same |